rHEALTH ONE small volume blood analyzer arrived at International Space Station on Feb. 21. Bedford, MA, February 19, 2022. rHEALTH, announced today that NASA has successfully launched its rHEALTH ONE blood analyzer to space on NASA Commercial Resupply Mission NG-17. The rHEALTH ONE was carried to the International Space Station (ISS) via the NG-17 Cygnus spacecraft,...Read more
Recent Posts by DMI
Grant supports efforts to utilize rHEALTH’s point-of-care technology for monitoring FVIII and emicizumab levels in hemophilia A patients BEDFORD, Mass., October 8, 2020 – rHEALTH LLC, a Diagnose Yourself, AnywhereTM company, today announced that its technology is the subject of the award from the National Institute of Health (NIH). The award is to rHEALTH’s affiliate,...Read more
Certification conforms to worldwide standard for medical device quality and together with the expansion, allows rHEALTH to meet its commercial objectives BEDFORD, Mass., April 22, 2020 – rHEALTH LLC, a Diagnose Yourself, AnywhereTM company, today announced that it has received ISO 13485:2016 certification for the design and development, production and distribution, and servicing of in vitro...Read more
Dear Stakeholder, These are challenging times. To me, there is no doubt that humankind will triumph. In doing so, it will show its resiliency, fortitude, and kindness in each of us. As a diagnostic provider, we are currently working with the US federal agencies and our global partner companies to see how our capabilities and expertise may...Read more
Invention enables manipulation of small blood samples for accurate point-of-care diagnosis BEDFORD, Mass., January 5, 2020 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., announced today the issuance of United States Patent Number 10,449,537 titled “Capillary manipulation of clinical samples.” The patent describes a system for collection and delivery of minute blood samples to...Read more
Recent Comments by DMI
No comments by DMI yet.